Search research articles
Contact Us
Filters
Showing results (261-270 of 274) with videos related to
Page
of 28
Sort By:
Brain : a Journal of Neurology
|
March 25, 2024
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia
Lianne M Reus, Iris E Jansen, Betty M Tijms, et al.
The American Journal of Surgical Pathology
|
April 9, 2024
The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic Neoplasms
Alice Chen, Natasha Sharma, Pragi Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Nature
|
July 29, 2011
Oxysterols direct immune cell migration via EBI2
Sébastien Hannedouche, Juan Zhang, Tangsheng Yi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 22, 2015
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
Ignacio F Mata, James B Leverenz, Daniel Weintraub, et al.
Cancer Chemotherapy and Pharmacology
|
April 18, 2022
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
Julia Manzo, Shannon Puhalla, Shalu Pahuja, et al.
JAMA Neurology
|
August 30, 2016
Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease
Marie Y Davis, Catherine O Johnson, James B Leverenz, et al.
NPJ Parkinson'S Disease
|
April 26, 2025
Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
Edward N Wilson, Jacob Umans, Michelle S Swarovski, et al.
Journal of the National Cancer Institute
|
January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T Flaherty, Robert Gray, Alice Chen, et al.
The Lancet. Neurology
|
August 15, 2015
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study
Mike A Nalls, Cory Y McLean, Jacqueline Rick, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 274) with videos related to
Sort By:
Page
of 28
Brain : a Journal of Neurology
|
March 25, 2024
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia
Lianne M Reus, Iris E Jansen, Betty M Tijms, et al.
The American Journal of Surgical Pathology
|
April 9, 2024
The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic Neoplasms
Alice Chen, Natasha Sharma, Pragi Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Nature
|
July 29, 2011
Oxysterols direct immune cell migration via EBI2
Sébastien Hannedouche, Juan Zhang, Tangsheng Yi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 22, 2015
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
Ignacio F Mata, James B Leverenz, Daniel Weintraub, et al.
Cancer Chemotherapy and Pharmacology
|
April 18, 2022
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
Julia Manzo, Shannon Puhalla, Shalu Pahuja, et al.
JAMA Neurology
|
August 30, 2016
Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease
Marie Y Davis, Catherine O Johnson, James B Leverenz, et al.
NPJ Parkinson'S Disease
|
April 26, 2025
Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
Edward N Wilson, Jacob Umans, Michelle S Swarovski, et al.
Journal of the National Cancer Institute
|
January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T Flaherty, Robert Gray, Alice Chen, et al.
The Lancet. Neurology
|
August 15, 2015
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study
Mike A Nalls, Cory Y McLean, Jacqueline Rick, et al.
Page
of 28